| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |